151 related articles for article (PubMed ID: 17505990)
21. Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists.
Fujisawa T; Adachi K; Komazawa Y; Mihara T; Azumi T; Katsube T; Furuta K; Kazumori H; Kinoshita Y
Aliment Pharmacol Ther; 2004 Sep; 20(5):559-65. PubMed ID: 15339327
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
Parkinson S; Tolbert K; Messenger K; Odunayo A; Brand M; Davidson G; Peters E; Reed A; Papich MG
J Vet Intern Med; 2015 Jan; 29(1):104-12. PubMed ID: 25537303
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitors reduce the bioavailability of dietary vitamin C.
Henry EB; Carswell A; Wirz A; Fyffe V; McColl KE
Aliment Pharmacol Ther; 2005 Sep; 22(6):539-45. PubMed ID: 16167970
[TBL] [Abstract][Full Text] [Related]
24. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
25. Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.
Luber AD; Brower R; Kim D; Silverman R; Peloquin CA; Frank I
HIV Med; 2007 Oct; 8(7):457-64. PubMed ID: 17760738
[TBL] [Abstract][Full Text] [Related]
26. Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa.
Ichikawa T; Ito Y; Saegusa Y; Iwai T; Goso Y; Ikezawa T; Ishihara K
J Gastroenterol Hepatol; 2009 Mar; 24(3):488-92. PubMed ID: 19175830
[TBL] [Abstract][Full Text] [Related]
27. Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.
Pais SA; Nathwani RA; Dhar V; Nowain A; Laine L
Aliment Pharmacol Ther; 2006 Jun; 23(11):1607-13. PubMed ID: 16696810
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of intravenous administration of combined acid suppressants in healthy dogs.
Tolbert MK; Odunayo A; Howell RS; Peters EE; Reed A
J Vet Intern Med; 2015; 29(2):556-60. PubMed ID: 25711717
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of the effects of famotidine and omeprazole in the prevention of the aspiration of gastric contents syndrome in elective surgery].
Seveso M; Pesci M; Lualdi M; Vimercati C; Battaglia G; Cammelli F
Minerva Anestesiol; 1992 Apr; 58(4):207-10. PubMed ID: 1620417
[TBL] [Abstract][Full Text] [Related]
30. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
31. Impact of stress ulcer prophylaxis algorithm study.
Coursol CJ; Sanzari SE
Ann Pharmacother; 2005 May; 39(5):810-6. PubMed ID: 15811900
[TBL] [Abstract][Full Text] [Related]
32. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the effects between standard doses of H2-blocker (famotidine 20mg b.d.) and proton pump inhibitor (omeprazole 20mg o.d.) in the treatment of refractory reflux esophagitis by ambulatory 24-hr intra-gastroesophageal pH monitoring].
Yamashita Y; Kinoshita Y; Chihara K; Chiba T
Nihon Shokakibyo Gakkai Zasshi; 1994 Dec; 91(12):2166-73. PubMed ID: 7837683
[TBL] [Abstract][Full Text] [Related]
34. Effects of combination therapy with pirenzepine and famotidine on tetragastrin-stimulated gastric secretion in humans.
Misawa T; Chijiiwa Y; Fujishima H; Harada N; Nawata H
Fukuoka Igaku Zasshi; 1991 Dec; 82(12):618-23. PubMed ID: 1783354
[TBL] [Abstract][Full Text] [Related]
35. Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs.
Tolbert MK; Graham A; Odunayo A; Price J; Steiner JM; Newkirk K; Hecht S
J Vet Intern Med; 2017 Jan; 31(1):117-123. PubMed ID: 27906465
[TBL] [Abstract][Full Text] [Related]
36. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Javsicas LH; Sanchez LC
Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
[TBL] [Abstract][Full Text] [Related]
37. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
Ono S; Kato M; Ono Y; Nakagawa M; Nakagawa S; Shimizu Y; Asaka M
Endoscopy; 2009 Apr; 41(4):299-303. PubMed ID: 19340731
[TBL] [Abstract][Full Text] [Related]
38. The frequency of oral famotidine administration influences its effect on gastric pH in cats over time.
Golly E; Odunayo A; Daves M; Vose J; Price J; Hecht S; Steiner JM; Hillsman S; Tolbert MK
J Vet Intern Med; 2019 Mar; 33(2):544-550. PubMed ID: 30746763
[TBL] [Abstract][Full Text] [Related]
39. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
